Companies: 10,786     total market cap: $133.918 T
โ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Brady Corporation
BRC
#3545
Rank
$3.83 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
$81.24
Share price
1.23%
Change (1 day)
15.84%
Change (1 year)
๐Ÿญ Manufacturing
Categories
  1. Brady Corporation
  2. Quarterly Reports (10-Q)
  3. Submitted on 2023-02-24

Brady Corporation - 10-Q quarterly report FY Q2


Text size:
false2023Q20000746598July 318,0977,35551,261,48751,261,48746,115,76046,370,7085,145,7274,890,7793,538,6283,538,6283,538,6283,538,62800007465982022-08-012023-01-310000746598us-gaap:NonvotingCommonStockMember2023-02-22xbrli:shares0000746598us-gaap:CommonClassBMember2023-02-2200007465982023-01-31iso4217:USD00007465982022-07-310000746598us-gaap:NonvotingCommonStockMember2023-01-310000746598us-gaap:NonvotingCommonStockMember2022-07-310000746598us-gaap:CommonClassBMember2023-01-310000746598us-gaap:CommonClassBMember2022-07-3100007465982022-11-012023-01-3100007465982021-11-012022-01-3100007465982021-08-012022-01-310000746598us-gaap:RetainedEarningsMember2022-11-012023-01-310000746598us-gaap:RetainedEarningsMember2021-11-012022-01-310000746598us-gaap:NonvotingCommonStockMember2022-11-012023-01-31iso4217:USDxbrli:shares0000746598us-gaap:NonvotingCommonStockMember2021-11-012022-01-310000746598us-gaap:NonvotingCommonStockMember2022-08-012023-01-310000746598us-gaap:NonvotingCommonStockMember2021-08-012022-01-310000746598us-gaap:CommonClassBMember2022-11-012023-01-310000746598us-gaap:CommonClassBMember2021-11-012022-01-310000746598us-gaap:CommonClassBMember2022-08-012023-01-310000746598us-gaap:CommonClassBMember2021-08-012022-01-310000746598us-gaap:CommonStockMember2022-10-310000746598us-gaap:AdditionalPaidInCapitalMember2022-10-310000746598us-gaap:RetainedEarningsMember2022-10-310000746598us-gaap:TreasuryStockMember2022-10-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-3100007465982022-10-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-11-012023-01-310000746598us-gaap:AdditionalPaidInCapitalMember2022-11-012023-01-310000746598us-gaap:TreasuryStockMember2022-11-012023-01-310000746598us-gaap:NonvotingCommonStockMemberus-gaap:RetainedEarningsMember2022-11-012023-01-310000746598us-gaap:CommonClassBMemberus-gaap:RetainedEarningsMember2022-11-012023-01-310000746598us-gaap:CommonStockMember2023-01-310000746598us-gaap:AdditionalPaidInCapitalMember2023-01-310000746598us-gaap:RetainedEarningsMember2023-01-310000746598us-gaap:TreasuryStockMember2023-01-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-310000746598us-gaap:CommonStockMember2022-07-310000746598us-gaap:AdditionalPaidInCapitalMember2022-07-310000746598us-gaap:RetainedEarningsMember2022-07-310000746598us-gaap:TreasuryStockMember2022-07-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-310000746598us-gaap:RetainedEarningsMember2022-08-012023-01-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-08-012023-01-310000746598us-gaap:AdditionalPaidInCapitalMember2022-08-012023-01-310000746598us-gaap:TreasuryStockMember2022-08-012023-01-310000746598us-gaap:NonvotingCommonStockMemberus-gaap:RetainedEarningsMember2022-08-012023-01-310000746598us-gaap:CommonClassBMemberus-gaap:RetainedEarningsMember2022-08-012023-01-310000746598us-gaap:CommonStockMember2021-10-310000746598us-gaap:AdditionalPaidInCapitalMember2021-10-310000746598us-gaap:RetainedEarningsMember2021-10-310000746598us-gaap:TreasuryStockMember2021-10-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-3100007465982021-10-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-11-012022-01-310000746598us-gaap:AdditionalPaidInCapitalMember2021-11-012022-01-310000746598us-gaap:TreasuryStockMember2021-11-012022-01-310000746598us-gaap:NonvotingCommonStockMemberus-gaap:RetainedEarningsMember2021-11-012022-01-310000746598us-gaap:CommonClassBMemberus-gaap:RetainedEarningsMember2021-11-012022-01-310000746598us-gaap:CommonStockMember2022-01-310000746598us-gaap:AdditionalPaidInCapitalMember2022-01-310000746598us-gaap:RetainedEarningsMember2022-01-310000746598us-gaap:TreasuryStockMember2022-01-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-3100007465982022-01-310000746598us-gaap:CommonStockMember2021-07-310000746598us-gaap:AdditionalPaidInCapitalMember2021-07-310000746598us-gaap:RetainedEarningsMember2021-07-310000746598us-gaap:TreasuryStockMember2021-07-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-3100007465982021-07-310000746598us-gaap:RetainedEarningsMember2021-08-012022-01-310000746598us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-08-012022-01-310000746598us-gaap:AdditionalPaidInCapitalMember2021-08-012022-01-310000746598us-gaap:TreasuryStockMember2021-08-012022-01-310000746598us-gaap:NonvotingCommonStockMemberus-gaap:RetainedEarningsMember2021-08-012022-01-310000746598us-gaap:CommonClassBMemberus-gaap:RetainedEarningsMember2021-08-012022-01-310000746598us-gaap:TradeNamesMember2022-08-012023-01-310000746598us-gaap:TradeNamesMember2023-01-310000746598us-gaap:TradeNamesMember2021-08-012022-07-310000746598us-gaap:TradeNamesMember2022-07-310000746598us-gaap:CustomerRelationshipsMember2022-08-012023-01-310000746598us-gaap:CustomerRelationshipsMember2023-01-310000746598us-gaap:CustomerRelationshipsMember2021-08-012022-07-310000746598us-gaap:CustomerRelationshipsMember2022-07-310000746598us-gaap:TechnologyBasedIntangibleAssetsMember2022-08-012023-01-310000746598us-gaap:TechnologyBasedIntangibleAssetsMember2023-01-310000746598us-gaap:TechnologyBasedIntangibleAssetsMember2021-08-012022-07-310000746598us-gaap:TechnologyBasedIntangibleAssetsMember2022-07-310000746598us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-07-310000746598us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-07-310000746598us-gaap:AccumulatedTranslationAdjustmentMember2022-07-310000746598us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-08-012023-01-310000746598us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-08-012023-01-310000746598us-gaap:AccumulatedTranslationAdjustmentMember2022-08-012023-01-310000746598us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-310000746598us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-01-310000746598us-gaap:AccumulatedTranslationAdjustmentMember2023-01-310000746598us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-07-310000746598us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-07-310000746598us-gaap:AccumulatedTranslationAdjustmentMember2021-07-310000746598us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-08-012022-01-310000746598us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2021-08-012022-01-310000746598us-gaap:AccumulatedTranslationAdjustmentMember2021-08-012022-01-310000746598us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-310000746598us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2022-01-310000746598us-gaap:AccumulatedTranslationAdjustmentMember2022-01-31utr:Rate0000746598srt:AmericasMemberbrc:IdSolutionsMember2022-11-012023-01-310000746598srt:AmericasMemberbrc:IdSolutionsMember2021-11-012022-01-310000746598srt:AmericasMemberbrc:IdSolutionsMember2022-08-012023-01-310000746598srt:AmericasMemberbrc:IdSolutionsMember2021-08-012022-01-310000746598us-gaap:EMEAMemberbrc:IdSolutionsMember2022-11-012023-01-310000746598us-gaap:EMEAMemberbrc:IdSolutionsMember2021-11-012022-01-310000746598us-gaap:EMEAMemberbrc:IdSolutionsMember2022-08-012023-01-310000746598us-gaap:EMEAMemberbrc:IdSolutionsMember2021-08-012022-01-310000746598brc:IdSolutionsMembersrt:AsiaPacificMember2022-11-012023-01-310000746598brc:IdSolutionsMembersrt:AsiaPacificMember2021-11-012022-01-310000746598brc:IdSolutionsMembersrt:AsiaPacificMember2022-08-012023-01-310000746598brc:IdSolutionsMembersrt:AsiaPacificMember2021-08-012022-01-310000746598brc:IdSolutionsMember2022-11-012023-01-310000746598brc:IdSolutionsMember2021-11-012022-01-310000746598brc:IdSolutionsMember2022-08-012023-01-310000746598brc:IdSolutionsMember2021-08-012022-01-310000746598brc:WorkplaceSafetyMembersrt:AmericasMember2022-11-012023-01-310000746598brc:WorkplaceSafetyMembersrt:AmericasMember2021-11-012022-01-310000746598brc:WorkplaceSafetyMembersrt:AmericasMember2022-08-012023-01-310000746598brc:WorkplaceSafetyMembersrt:AmericasMember2021-08-012022-01-310000746598us-gaap:EMEAMemberbrc:WorkplaceSafetyMember2022-11-012023-01-310000746598us-gaap:EMEAMemberbrc:WorkplaceSafetyMember2021-11-012022-01-310000746598us-gaap:EMEAMemberbrc:WorkplaceSafetyMember2022-08-012023-01-310000746598us-gaap:EMEAMemberbrc:WorkplaceSafetyMember2021-08-012022-01-310000746598brc:WorkplaceSafetyMembersrt:AsiaPacificMember2022-11-012023-01-310000746598brc:WorkplaceSafetyMembersrt:AsiaPacificMember2021-11-012022-01-310000746598brc:WorkplaceSafetyMembersrt:AsiaPacificMember2022-08-012023-01-310000746598brc:WorkplaceSafetyMembersrt:AsiaPacificMember2021-08-012022-01-310000746598brc:WorkplaceSafetyMember2022-11-012023-01-310000746598brc:WorkplaceSafetyMember2021-11-012022-01-310000746598brc:WorkplaceSafetyMember2022-08-012023-01-310000746598brc:WorkplaceSafetyMember2021-08-012022-01-310000746598srt:AmericasMember2022-11-012023-01-310000746598srt:AmericasMember2021-11-012022-01-310000746598srt:AmericasMember2022-08-012023-01-310000746598srt:AmericasMember2021-08-012022-01-310000746598us-gaap:EMEAMember2022-11-012023-01-310000746598us-gaap:EMEAMember2021-11-012022-01-310000746598us-gaap:EMEAMember2022-08-012023-01-310000746598us-gaap:EMEAMember2021-08-012022-01-310000746598srt:AsiaPacificMember2022-11-012023-01-310000746598srt:AsiaPacificMember2021-11-012022-01-310000746598srt:AsiaPacificMember2022-08-012023-01-310000746598srt:AsiaPacificMember2021-08-012022-01-310000746598us-gaap:FairValueInputsLevel1Memberus-gaap:OtherAssetsMember2023-01-310000746598us-gaap:FairValueInputsLevel1Memberus-gaap:OtherAssetsMember2022-07-310000746598us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2023-01-310000746598us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2022-07-310000746598us-gaap:FairValueInputsLevel2Memberus-gaap:OtherCurrentLiabilitiesMember2023-01-310000746598us-gaap:FairValueInputsLevel2Memberus-gaap:OtherCurrentLiabilitiesMember2022-07-310000746598us-gaap:DesignatedAsHedgingInstrumentMember2023-01-310000746598us-gaap:DesignatedAsHedgingInstrumentMember2022-07-310000746598us-gaap:NondesignatedMember2023-01-310000746598us-gaap:NondesignatedMember2022-07-310000746598us-gaap:NetInvestmentHedgingMember2023-01-310000746598us-gaap:NetInvestmentHedgingMember2022-07-310000746598us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-01-310000746598us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2023-01-310000746598us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-07-310000746598us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMember2022-07-310000746598us-gaap:LongTermDebtMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-310000746598us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2023-01-310000746598us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2023-01-310000746598us-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2022-07-310000746598us-gaap:NondesignatedMemberus-gaap:OtherCurrentLiabilitiesMember2022-07-310000746598us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2023-01-310000746598us-gaap:OtherCurrentLiabilitiesMember2023-01-310000746598us-gaap:LongTermDebtMember2023-01-310000746598us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-07-310000746598us-gaap:OtherCurrentLiabilitiesMember2022-07-3100007465982023-02-012023-02-210000746598us-gaap:SubsequentEventMember2023-02-212023-02-210000746598us-gaap:SubsequentEventMember2023-02-210000746598us-gaap:SubsequentEventMember2023-04-282023-04-280000746598us-gaap:SubsequentEventMember2023-04-102023-04-10
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended January 31, 2023
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period from                     to                     
Commission File Number 1-14959
BRADY CORPORATION
(Exact name of registrant as specified in its charter)
Wisconsin 39-0178960
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)
6555 West Good Hope Road
Milwaukee, Wisconsin 53223
(Address of principal executive offices and zip code)
(414) 358-6600
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Class A Nonvoting Common Stock, par value $0.01 per shareBRCNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes  ☑   No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☑  No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☑Accelerated filer ☐Emerging growth company☐
Non-accelerated filer ☐Smaller reporting company ☐ 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐ No  ☑ 
As of February 22, 2023, there were 46,121,200 outstanding shares of Class A Nonvoting Common Stock and 3,538,628 shares of Class B Voting Common Stock. The Class B Voting Common Stock, all of which is held by affiliates of the Registrant, is the only voting stock.

Table of Contents
FORM 10-Q
BRADY CORPORATION
INDEX
 
2
Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS

BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)

January 31, 2023July 31, 2022
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$108,210 $114,069 
Accounts receivable, net of allowance for credit losses of $8,097 and $7,355, respectively
186,852 183,233 
Inventories195,167 190,023 
Prepaid expenses and other current assets13,986 10,743 
Total current assets504,215 498,068 
Property, plant and equipment—net140,784 139,511 
Goodwill590,776 586,832 
Other intangible assets67,513 74,028 
Deferred income taxes15,826 15,881 
Operating lease assets31,411 31,293 
Other assets21,748 21,719 
Total$1,372,273 $1,367,332 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$75,876 $81,116 
Accrued compensation and benefits53,213 76,764 
Taxes, other than income taxes12,799 12,539 
Accrued income taxes6,794 8,294 
Current operating lease liabilities15,402 15,003 
Other current liabilities65,765 61,458 
Total current liabilities229,849 255,174 
Long-term debt77,281 95,000 
Long-term operating lease liabilities17,822 19,143 
Other liabilities79,917 86,717 
Total liabilities404,869 456,034 
Stockholders’ equity:
Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 46,115,760 and 46,370,708 shares, respectively
513 513 
Class B voting common stock—Issued and outstanding, 3,538,628 shares
35 35 
Additional paid-in capital348,513 345,266 
Retained earnings947,051 892,417 
Treasury stock—5,145,727 and 4,890,779 shares, respectively, of Class A nonvoting common stock, at cost
(233,338)(217,856)
Accumulated other comprehensive loss(95,370)(109,077)
Total stockholders’ equity967,404 911,298 
Total$1,372,273 $1,367,332 

See Notes to Condensed Consolidated Financial Statements.
3
Table of Contents
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in Thousands, Except Per Share Amounts, Unaudited)

Three months ended January 31,Six months ended January 31,
 2023202220232022
Net sales$326,249 $318,055 $648,818 $639,530 
Cost of goods sold169,809 168,693 337,114 335,180 
Gross margin156,440 149,362 311,704 304,350 
Operating expenses:
Research and development15,377 13,965 29,310 27,872 
Selling, general and administrative92,282 92,525 182,227 189,271 
Total operating expenses107,659 106,490 211,537 217,143 
Operating income 48,781 42,872 100,167 87,207 
Other income (expense):
Investment and other income (expense)968 (578)811 (35)
Interest expense(1,239)(252)(2,133)(434)
Income before income taxes48,510 42,042 98,845 86,738 
Income tax expense10,524 8,227 21,418 17,877 
Net income$37,986 $33,815 $77,427 $68,861 
Net income per Class A Nonvoting Common Share:
Basic$0.76 $0.65 $1.55 $1.33 
Diluted$0.76 $0.65 $1.55 $1.32 
Net income per Class B Voting Common Share:
Basic$0.76 $0.65 $1.54 $1.31 
Diluted$0.76 $0.65 $1.53 $1.30 
Weighted average common shares outstanding:
Basic49,745 51,800 49,806 51,887 
Diluted50,009 52,162 50,049 52,299 

See Notes to Condensed Consolidated Financial Statements.
4
Table of Contents
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Dollars in Thousands, Unaudited)

Three months ended January 31,Six months ended January 31,
 2023202220232022
Net income$37,986 $33,815 $77,427 $68,861 
Other comprehensive income (loss):
Foreign currency translation adjustments30,562 (18,656)12,890 (22,574)
Cash flow hedges:
Net gain recognized in other comprehensive income (loss)776 225 1,669 199 
Reclassification adjustment for gains included in net income(217)(35)(798)(603)
559 190 871 (404)
Pension and other post-retirement benefits:
Net loss recognized in other comprehensive income (loss)— (85)— (85)
Net actuarial loss (gain) amortization27 (73)(116)(180)
27 (158)(116)(265)
Other comprehensive income (loss), before tax31,148 (18,624)13,645 (23,243)
Income tax (expense) benefit related to items of other comprehensive income (loss)(4)356 62 257 
Other comprehensive income (loss), net of tax31,144 (18,268)13,707 (22,986)
Comprehensive income$69,130 $15,547 $91,134 $45,875 

See Notes to Condensed Consolidated Financial Statements.
5
Table of Contents
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Dollars in Thousands, Unaudited)
Three months ended January 31, 2023
Common StockAdditional
 Paid-In Capital		Retained EarningsTreasury StockAccumulated Other Comprehensive LossTotal Stockholders' Equity
Balances at October 31, 2022$548 $346,064 $920,482 $(228,855)$(126,514)$911,725 
Net income— — 37,986 — — 37,986 
Other comprehensive income, net of tax— — — — 31,144 31,144 
Issuance of shares of Class A Common Stock under stock plan— 1,026 — 1,308 — 2,334 
Stock-based compensation expense— 1,423 — — — 1,423 
Repurchase of shares of Class A Common Stock— — — (5,791)— (5,791)
Cash dividends on Common Stock:
Class A — $0.2300 per share
— — (10,603)— — (10,603)
Class B — $0.2300 per share
— — (814)— — (814)
Balances at January 31, 2023$548 $348,513 $947,051 $(233,338)$(95,370)$967,404 
Six months ended January 31, 2023
Common StockAdditional
 Paid-In Capital		Retained EarningsTreasury StockAccumulated Other Comprehensive LossTotal Stockholders' Equity
Balances at July 31, 2022$548 $345,266 $892,417 $(217,856)$(109,077)$911,298 
Net income— — 77,427 — — 77,427 
Other comprehensive income, net of tax— — — — 13,707 13,707 
Issuance of shares of Class A Common Stock under stock plan— (1,200)— 2,379 — 1,179 
Tax benefit and withholdings from deferred compensation distributions— 66 — — — 66 
Stock-based compensation expense— 4,381 — — — 4,381 
Repurchase of shares of Class A Common Stock— — — (17,861)— (17,861)
Cash dividends on Common Stock:
Class A — $0.4600 per share
— — (21,224)— — (21,224)
Class B — $0.4434 per share
— — (1,569)— — (1,569)
Balances at January 31, 2023$548 $348,513 $947,051 $(233,338)$(95,370)$967,404 

6
Table of Contents

Three months ended January 31, 2022
Common StockAdditional
 Paid-In Capital		Retained EarningsTreasury StockAccumulated Other Comprehensive LossTotal Stockholders' Equity
Balances at October 31, 2021$548 $340,182 $811,820 $(127,986)$(60,671)$963,893 
Net income— — $33,815 — — 33,815 
Other comprehensive loss, net of tax— — — — (18,268)(18,268)
Issuance of shares of Class A Common Stock under stock plan— (1,334)— (129)— (1,463)
Stock-based compensation expense— 3,041 — — — 3,041 
Repurchase of shares of Class A Common Stock— — — (2,796)— (2,796)
Cash dividends on Common Stock:
Class A — $0.2250 per share
— — (10,857)— — (10,857)
Class B — $0.2250 per share
— — (797)— — (797)
Balances at January 31, 2022$548 $341,889 $833,981 $(130,911)$(78,939)$966,568 
Six months ended January 31, 2022
Common StockAdditional
 Paid-In Capital		Retained EarningsTreasury StockAccumulated Other Comprehensive LossTotal Stockholders' Equity
Balances at July 31, 2021$548 $339,125 $788,369 $(109,061)$(55,953)$963,028 
Net income— — 68,861 — — 68,861 
Other comprehensive income, net of tax— — — — (22,986)(22,986)
Issuance of shares of Class A Common Stock under stock plan— (4,521)— (130)— (4,651)
Tax benefit and withholdings from deferred compensation distributions— 115 — — — 115 
Stock-based compensation expense— 7,170 — — — 7,170 
Repurchase of shares of Class A Common Stock— — — (21,720)— (21,720)
Cash dividends on Common Stock:
Class A — $0.4500 per share
— — (21,715)— — (21,715)
Class B — $0.4334 per share
— — (1,534)— — (1,534)
Balances at January 31, 2022$548 $341,889 $833,981 $(130,911)$(78,939)$966,568 

7
Table of Contents
BRADY CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in Thousands, Unaudited)

Six months ended January 31,
 20232022
Operating activities:
Net income$77,427 $68,861 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization17,117 16,996 
Stock-based compensation expense4,381 7,170 
Deferred income taxes(5,234)(788)
Other(908)(812)
Changes in operating assets and liabilities:
Accounts receivable280 (7,216)
Inventories(1,287)(34,360)
Prepaid expenses and other assets(3,502)(1,148)
Accounts payable and accrued liabilities(29,156)(25,357)
Income taxes(1,734)982 
Net cash provided by operating activities57,384 24,328 
Investing activities:
Purchases of property, plant and equipment(8,167)(16,440)
Other11 59 
Net cash used in investing activities(8,156)(16,381)
Financing activities:
Payment of dividends(22,793)(23,249)
Proceeds from exercise of stock options2,688 374 
Payments for employee taxes withheld from stock-based awards(1,509)(5,025)
Purchase of treasury stock(17,861)(21,720)
Proceeds from borrowing on credit agreement71,036 131,216 
Repayment of borrowing on credit agreement(88,755)(86,216)
Other66 115 
Net cash used in financing activities(57,128)(4,505)
Effect of exchange rate changes on cash and cash equivalents2,041 (3,370)
Net (decrease) increase in cash and cash equivalents
(5,859)72 
Cash and cash equivalents, beginning of period114,069 147,335 
Cash and cash equivalents, end of period$108,210 $147,407 

See Notes to Condensed Consolidated Financial Statements.
8
Table of Contents
BRADY CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Six Months Ended January 31, 2023
(Unaudited)
(In thousands, except share and per share amounts)
NOTE A — Basis of Presentation
The condensed consolidated financial statements included herein have been prepared by Brady Corporation and subsidiaries (the "Company," "Brady," "we," or "our") without audit, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of the Company, the foregoing statements contain all adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial position of the Company as of January 31, 2023 and July 31, 2022, its results of operations and comprehensive income for the three and six months ended January 31, 2023 and 2022, and cash flows for the six months ended January 31, 2023 and 2022. The condensed consolidated balance sheet as of July 31, 2022, has been derived from the audited consolidated financial statements as of that date. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts therein. Due to the inherent uncertainty involved in making estimates, actual results in future periods may differ from the estimates.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to rules and regulations of the Securities and Exchange Commission. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statement presentation. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended July 31, 2022.

NOTE B — New Accounting Pronouncements
Adopted Standards
In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities (e.g. deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, “Revenue from Contracts with Customers” as if the acquirer had originated the contracts. The guidance is applied prospectively to acquisitions occurring on or after the effective date. The Company early adopted ASU No. 2021-08 during the quarter ended October 31, 2022. The adoption of the new standard will only have an impact on the Company's condensed consolidated financial statements in the event of future acquisitions.

NOTE C — Additional Balance Sheet Information
Inventories
Inventories as of January 31, 2023, and July 31, 2022, consisted of the following:
 January 31, 2023July 31, 2022
Finished products$109,617 $112,323 
Work-in-process30,572 29,272 
Raw materials and supplies54,978 48,428 
Total inventories$195,167 $190,023 
Property, plant and equipment
Property, plant and equipment is presented net of accumulated depreciation in the amount of $284,186 and $272,376 as of January 31, 2023, and July 31, 2022, respectively.

9
Table of Contents
NOTE D — Other Intangible Assets
Other intangible assets as of January 31, 2023 and July 31, 2022, consisted of the following: 
 January 31, 2023July 31, 2022
Weighted Average Amortization Period (Years)Gross Carrying AmountAccumulated AmortizationNet Book ValueWeighted Average Amortization Period (Years)Gross Carrying AmountAccumulated AmortizationNet Book Value
Amortized other intangible assets:
Tradenames3$1,757 $(1,353)$404 3$1,749 $(1,014)$735 
Customer relationships9105,842 (54,149)51,693 9105,404 (48,428)56,976 
Technology59,204 (3,221)5,983 59,136 (2,241)6,895 
Unamortized other intangible assets:
TradenamesN/A9,433 — 9,433 N/A9,422 — 9,422 
Total$126,236 $(58,723)$67,513 $125,711 $(51,683)$74,028 
The change in the gross carrying amount of other intangible assets as of January 31, 2023 compared to July 31, 2022 was due to the effect of currency fluctuations during the six-month period.
Amortization expense of intangible assets was $3,258 and $3,749 for the three months ended January 31, 2023 and 2022, respectively, and $6,889 and $7,556 for the six months ended January 31, 2023 and 2022, respectively.

NOTE E — Leases
The Company leases certain manufacturing facilities, warehouse and office spaces, and vehicles accounted for as operating leases. Lease terms typically range from one year to ten years. As of January 31, 2023, the Company did not have any finance leases.
Operating lease expense was $3,868 and $4,087 for the three months ended January 31, 2023 and 2022, respectively, and $7,648 and $8,852 for the six months ended January 31, 2023 and 2022, respectively, which was recognized in either "Cost of goods sold" or "Selling, general and administrative" expenses in the condensed consolidated statements of income, based on the nature of the lease. Short-term lease expense, variable lease expenses, and sublease income was immaterial to the condensed consolidated statements of income for the three and six months ended January 31, 2023 and 2022.
Supplemental cash flow information related to the Company's operating leases for the six months ended January 31, 2023 and 2022, was as follows:
Six months ended January 31,
20232022
Operating cash outflows from operating leases$8,766 $9,805 
Operating lease assets obtained in exchange for new operating lease liabilities (1)
6,545 952 
(1) Includes new leases and remeasurements or modifications of existing leases.

NOTE F — Accumulated Other Comprehensive Loss
Other comprehensive loss consists of foreign currency translation adjustments, unrealized gains and losses from cash flow hedges, and the unamortized gain on post-retirement plans, net of their related tax effects.
10
Table of Contents
The following table illustrates the changes in the balances of each component of accumulated other comprehensive loss, net of tax, for the six months ended January 31, 2023:
Unrealized gain on cash flow hedgesUnamortized gain on post-retirement plansForeign currency translation adjustmentsAccumulated other comprehensive loss
Beginning balance, July 31, 2022$954 $1,436 $(111,467)$(109,077)
Other comprehensive income (loss) before reclassification1,593 — 12,890 14,483 
Amounts reclassified from accumulated other comprehensive loss(598)(178)— (776)
Ending balance, January 31, 2023$1,949 $1,258 $(98,577)$(95,370)
The decrease in accumulated other comprehensive loss as of January 31, 2023 compared to July 31, 2022 was primarily due to the depreciation of the U.S. dollar against certain other currencies during the six-month period. The foreign currency translation adjustments column in the table above includes the impact of foreign currency translation, foreign currency translation on intercompany notes, and the settlements of net investment hedges, net of tax.
The changes in accumulated other comprehensive loss by component, net of tax, for the six months ended January 31, 2022 were as follows:
Unrealized gain on cash flow hedgesUnamortized gain on post-retirement plansForeign currency translation adjustmentsAccumulated other comprehensive loss
Beginning balance, July 31, 2021$729 $1,888 $(58,570)$(55,953)
Other comprehensive loss before reclassification(142)(60)(22,141)(22,343)
Amounts reclassified from accumulated other comprehensive loss(453)(190)— (643)
Ending balance, January 31, 2022$134 $1,638 $(80,711)$(78,939)
The increase in accumulated other comprehensive loss as of January 31, 2022, compared to July 31, 2021, was primarily due to the appreciation of the U.S. dollar against certain other currencies during the six-month period.
Of the amounts reclassified from accumulated other comprehensive loss during the six months ended January 31, 2023 and 2022, unrealized gains on cash flow hedges were reclassified to "Cost of goods sold" and unamortized gains on post-retirement plans were reclassified into "Investment and other income" on the condensed consolidated statements of income.
The following table illustrates the income tax benefit (expense) on the components of other comprehensive income (loss) for the three and six months ended January 31, 2023 and 2022:
Three months ended January 31,Six months ended January 31,
2023202220232022
Income tax (expense) benefit related to items of other comprehensive income (loss):
Cash flow hedges$58 $(87)$124 $(191)
Pension and other post-retirement benefits(62)15 (62)15 
Other income tax adjustments and currency translation— 428 — 433 
Income tax (expense) benefit related to items of other comprehensive income (loss):$(4)$356 $62 $257 

NOTE G — Revenue Recognition
The Company recognizes revenue when control of the product or service transfers to the customer at an amount that represents the consideration expected to be received in exchange for those products and services. The Company’s revenues are primarily from the sale of identification solutions and workplace safety products that are shipped and billed to customers. All revenue is from contracts with customers and is included in “Net sales” on the condensed consolidated statements of income. See Note H, “Segment Information,” for the Company’s disaggregated revenue disclosure.
11
Table of Contents
The Company offers extended warranty coverage that is included in the sales price of certain products, which it accounts for as service warranties. The Company accounts for the deferred revenue associated with extended service warranties as a contract liability. The balance of contract liabilities associated with service warranty performance obligations was $2,728 and $2,675 as of January 31, 2023 and July 31, 2022, respectively. The current portion and non-current portion of contract liabilities are included in “Other current liabilities” and “Other liabilities," respectively, on the condensed consolidated balance sheets. The Company recognized revenue of $311 and $296 during the three months ended January 31, 2023 and 2022, respectively, and $617 and $585 during the six months ended January 31, 2023 and 2022, respectively, that was included in the contract liability balance at the beginning of the respective period from the amortization of extended service warranties. Of the contract liability balance outstanding at January 31, 2023, the Company expects to recognize 22% by the end of fiscal 2023, an additional 34% by the end of fiscal 2024, and the remaining balance thereafter. 

NOTE H — Segment Information
The Company is organized and managed on a global basis within three operating segments, Identification Solutions ("IDS"), Workplace Safety ("WPS"), and People Identification ("PDC"), which aggregate into two reportable segments that are organized around businesses with consistent products and services: IDS and WPS. The IDS and PDC operating segments aggregate into the IDS reporting segment, while the WPS reporting segment is comprised solely of the Workplace Safety operating segment.
The following is a summary of net sales by segment and geographic region for the three and six months ended January 31, 2023 and 2022:
Three months ended January 31,Six months ended January 31,
2023202220232022
Net sales:
IDS
Americas$176,893 $158,999 $350,242 $323,909 
Europe54,797 57,274 111,440 114,163 
Asia23,993 28,713 50,357 55,531 
Total$255,683 $244,986 $512,039 $493,603 
WPS
Americas$19,182 $20,131 $37,964 $41,273 
Europe38,962 41,432 72,511 79,454 
Australia12,422 11,506 26,304 25,200 
Total$70,566 $73,069 $136,779 $145,927 
Total Company
Americas$196,075 $179,130 $388,206 $365,182 
Europe93,759 98,706 183,951 193,617 
Asia-Pacific36,415 40,219 76,661 80,731 
Total$326,249 $318,055 $648,818 $639,530 
The following is a summary of segment profit for the three and six months ended January 31, 2023 and 2022:
Three months ended January 31,Six months ended January 31,
 2023202220232022
Segment profit:
IDS$47,384 $44,129 $98,909 $92,945 
WPS6,249 4,515 12,627 6,808 
Total Company$53,633 $48,644 $111,536 $99,753 
12
Table of Contents
The following is a reconciliation of segment profit to income before income taxes for the three and six months ended January 31, 2023 and 2022:
Three months ended January 31,Six months ended January 31,
 2023202220232022
Total profit from reportable segments$53,633 $48,644 $111,536 $99,753 
Unallocated amounts:
Administrative costs(4,852)(5,772)(11,369)(12,546)
Investment and other income (expense)968 (578)811 (35)
Interest expense(1,239)(252)(2,133)(434)
Income before income taxes$48,510 $42,042 $98,845 $86,738 

NOTE I — Net Income per Common Share
Reconciliations of the numerator and denominator of the basic and diluted per share computations for the Company’s Class A and Class B common stock are summarized as follows:
Three months ended January 31,Six months ended January 31,
 2023202220232022
Numerator (in thousands):
Net income (Numerator for basic and diluted income per Class A Nonvoting Common Share)$37,986 $33,815 $77,427 $68,861 
Less:
Preferential dividends— — (769)(803)
Preferential dividends on dilutive stock options— — (4)(8)
Numerator for basic and diluted income per Class B Voting Common Share$37,986 $33,815 $76,654 $68,050 
Denominator: (in thousands)
Denominator for basic income per share for both Class A and Class B49,745 51,800 49,806 51,887 
Plus: Effect of dilutive equity awards264 362 243 412 
Denominator for diluted income per share for both Class A and Class B50,009 52,162 50,049 52,299 
Net income per Class A Nonvoting Common Share:
Basic$0.76 $0.65 $1.55 $1.33 
Diluted$0.76 $0.65 $1.55 $1.32 
Net income per Class B Voting Common Share:
Basic$0.76 $0.65 $1.54 $1.31 
Diluted$0.76 $0.65 $1.53 $1.30 
Potentially dilutive securities attributable to outstanding stock options and restricted stock units were excluded from the calculation of diluted earnings per share where the combined exercise price and average unamortized fair value were greater than the average market price of the Company's Class A Nonvoting Common Stock because the effect would have been anti-dilutive. The amount of anti-dilutive shares were 634,999 and 471,377 for the three months ended January 31, 2023 and 2022, respectively, and 609,266 and 475,489 for the six months ended January 31, 2023 and 2022, respectively.

NOTE J — Fair Value Measurements
In accordance with fair value accounting guidance, the Company determines fair value based on the exchange price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. The inputs used to measure fair value are classified into the following hierarchy:
Level 1 — Unadjusted quoted prices in active markets for identical instruments that are accessible as of the reporting date.
Level 2 — Other significant pricing inputs that are either directly or indirectly observable.
Level 3 — Significant unobservable pricing inputs, which result in the use of management's own assumptions.
13
Table of Contents
The following table summarizes the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of January 31, 2023 and July 31, 2022:
 January 31, 2023July 31, 2022Fair Value Hierarchy
Assets:
Deferred compensation plan assets$17,558 $18,037 Level 1
Foreign exchange contracts1,591 489 Level 2
Liabilities:
Foreign exchange contracts(116)32 Level 2
The following methods and assumptions were used to estimate the fair value of each class of financial instrument:
Deferred compensation plan assets: The Company’s deferred compensation investments consist of investments in mutual funds, which are included in "Other assets" on the condensed consolidated balance sheets. These investments were classified as Level 1 as the shares of these investments trade with sufficient frequency and volume to enable us to obtain pricing information on an ongoing basis.
Foreign exchange contracts: The Company’s foreign exchange contracts were classified as Level 2 as the fair value was based on the present value of the future cash flows using external models that use observable inputs, such as interest rates, yield curves and foreign exchange rates. See Note K, “Derivatives and Hedging Activities,” for additional information.
The fair values of cash and cash equivalents, accounts receivable, accounts payable, and other liabilities approximated carrying values due to their short-term nature.

NOTE K — Derivatives and Hedging Activities
The Company utilizes forward foreign exchange currency contracts to reduce the exchange rate risk of specific foreign currency denominated transactions. These contracts typically require the exchange of a foreign currency for U.S. dollars at a fixed rate on a future date, with maturities of less than 18 months, which qualify as cash flow hedges or net investment hedges under the accounting guidance for derivative instruments and hedging activities. The primary objective of the Company’s foreign currency exchange risk management program is to minimize the impact of currency movements due to transactions in other than the respective subsidiaries’ functional currency and to minimize the impact of currency movements on the Company’s net investment denominated in a currency other than the U.S. dollar. To achieve this objective, the Company hedges a portion of known exposures using forward foreign exchange currency contracts.
Main foreign currency exposures are related to transactions denominated in the British Pound, Euro, Canadian dollar, Australian dollar, Mexican Peso, Chinese Yuan, Malaysian Ringgit and Singapore dollar. Generally, these risk management transactions will involve the use of foreign currency derivatives to minimize the impact of currency movements on non-functional currency transactions.
The U.S. dollar equivalent notional amounts of outstanding forward exchange contracts were as follows:
January 31, 2023July 31, 2022
Designated as cash flow hedges$12,651 $25,276 
Non-designated hedges4,456 4,057 
Total foreign exchange contracts$17,107 $29,333 
Cash Flow Hedges
The Company has designated a portion of its forward foreign exchange contracts as cash flow hedges and recorded these contracts at fair value on the condensed consolidated balance sheets. For these instruments, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive income ("OCI") and reclassified into income in the same period or periods during which the hedged transaction affects income. As of January 31, 2023 and July 31, 2022, unrealized gains of $1,911 and $1,040 have been included in OCI, respectively.
14
Table of Contents
Net Investment Hedges
The Company has designated certain third party foreign currency denominated debt borrowed under its credit agreement as net investment hedges. These debt obligations, denominated in Euros and British Pounds, were designated as net investment hedges to hedge portions of the Company's net investment in its European operations. The Company’s foreign currency denominated debt obligations are valued under a market approach using publicized spot prices, and the net gains or losses attributable to the changes in spot prices are recorded as cumulative translation within AOCI and are included in the foreign currency translation adjustments section of the condensed consolidated statements of comprehensive income. As of January 31, 2023 and July 31, 2022, the cumulative balance recognized in accumulated other comprehensive income were losses of $841 and $0, respectively, on any outstanding foreign currency denominated debt obligations.
The following table summarizes the amount of pre-tax gains and losses related to derivatives designated as hedging instruments:
Three months ended January 31,Six months ended January 31,
  2023202220232022
Gains (losses) recognized in OCI:
Forward exchange contracts (cash flow hedges)$776 $225 $1,669 $199 
Foreign currency denominated debt (net investment hedges)(841)— (841)— 
Gains reclassified from OCI into cost of goods sold
Forward exchange contracts (cash flow hedges)217 36 798 604 
Fair values of derivative instruments in the condensed consolidated balance sheets were as follows:
 January 31, 2023July 31, 2022
Prepaid expenses and other current assetsOther current liabilitiesLong-term obligationsPrepaid expenses and other current assetsOther current liabilities
Derivatives designated as hedging instruments:
Foreign exchange contracts (cash flow hedges)$1,564 (116)— $489 $30 
Foreign currency denominated debt (net investment hedges)— — (38,981)— — 
Derivatives not designated as hedging instruments:
Foreign exchange contracts (non-designated hedges)27 — — — 2 
Total derivative instruments$1,591 (116)(38,981)$489 $32 

NOTE L — Income Taxes
The income tax rate for the three months ended January 31, 2023 and 2022, was 21.7% and 19.6%, respectively. The income tax rate for the six months ended January 31, 2023 and 2022, was 21.7% and 20.6%, respectively. The Company expects its ongoing annual income tax rate to be between 20% and 21% based on its current global business mix and based on tax laws and statutory tax rates currently in effect.

NOTE M — Subsequent Events
Effective February 1, 2023, the Company announced a modification of its organizational structure under new regional operating segments. Beginning in the third quarter of fiscal 2023, the Company will report sales and segment profit based on the following two operating segments: Americas & Asia and Europe & Australia.
On February 21, 2023, the Board of Directors declared a quarterly cash dividend to shareholders of the Company’s Class A and Class B Common Stock of $0.23 per share payable on April 28, 2023, to shareholders of record at the close of business on April 10, 2023.

15
Table of Contents
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Overview
Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative identification and healthcare products. The WPS segment manufactures a broad range of stock and custom identification products and sells a broad range of resale products.
The ability to provide customers with a broad range of proprietary, customized and diverse products for use in various applications across multiple industries and geographies, along with a commitment to quality and service, have made Brady a leader in many of its markets. Brady's long-term sales growth and profitability will depend not only on the overall economic environment and our ability to successfully navigate changes in the macro environment, but also on our ability to develop and market innovative new products, deliver a high level of customer service, advance our digital capabilities, and continuously improve the efficiency of our global operations. In our IDS business, our strategy for growth includes an increased focus on certain industries and products, a focus on improving the customer buying experience, and the development of technologically advanced, innovative and proprietary products. In our WPS business, our strategy for growth includes a focus on workplace safety critical industries, streamlining our product offerings, enhancing our compliance and customization expertise, improving our price competitiveness, and improving our digital capabilities.
The following are key initiatives supporting our strategy in fiscal 2023:
•Investing in organic growth by enhancing our research and development process and utilizing customer feedback and observations to develop innovative new products that solve customer needs and improve environmental sustainability.
•Providing our customers with the highest level of customer service.
•Expanding and enhancing our sales capabilities through an improved digital presence and the use of data-driven marketing automation tools.
•Maintaining profitability through pricing mechanisms to mitigate the impacts of ongoing supply chain disruptions and inflationary pressures while ensuring prices are market competitive.
•Investing in acquisitions that enhance our strategic position and accelerate long-term sales growth and profitability.
•Driving operational excellence and executing sustainable efficiency gains within our selling, general and administrative structures and within our global operations including insourcing of critical products and manufacturing activities while reducing our environmental footprint and managing working capital.
•Building on our culture of diversity, equity and inclusion to increase employee engagement and enhance recruitment and retention practices in order to drive differentiated performance and execute our strategy.
•Executing our reorganization to a regional operating structure to support continued growth in key geographies, facilitate new product development in our recent acquisitions, and simplify and further integrate our businesses.
Macroeconomic Conditions and Trends
The Company has experienced, and expects to continue to experience, inflationary pressures; labor shortages in certain geographies; supply chain and other business disruptions as a result of the conflict in Ukraine; as well as disruptions caused by COVID-19 and government-mandated actions in response to COVID-19, particularly in China. The Company has taken and will continue to take actions to mitigate inflation issues through pricing actions and the execution of sustainable efficiency gains.
We believe we have the financial strength to continue to invest in organic sales growth opportunities including sales, marketing, and research and development ("R&D") and inorganic sales opportunities including acquisitions, while continuing to drive sustainable efficiency gains and automation in our operations and selling, general and administrative ("SG&A") functions. At January 31, 2023, we had cash of $108.2 million, as well as a credit agreement with $221.1 million available for future borrowing, which can be increased up to $981.1 million at the Company's option and subject to certain conditions, for total available liquidity of $1,089.3 million.
We believe that our financial resources and liquidity levels, including the remaining undrawn amount of our credit agreement and our ability to increase our credit line as necessary, are sufficient to manage the impact of economic or geopolitical events which may result in reduced sales, reduced net income, and reduced cash provided by operating activities. Refer to Risk Factors, included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended July 31, 2022, for further discussion of the potential impact of global economic or geopolitical events or the COVID-19 pandemic on our business.

16
Table of Contents
Results of Operations
A comparison of results of operating income for the three and six months ended January 31, 2023 and 2022, is as follows:
Three months ended January 31,Six months ended January 31,
(Dollars in thousands)2023% Sales2022% Sales2023% Sales2022% Sales
Net sales$326,249 $318,055 $648,818 $639,530 
Gross margin156,440 48.0 %149,362 47.0 %311,704 48.0 %304,350 47.6 %
Operating expenses:
Research and development15,377 4.7 %13,965 4.4 %29,310 4.5 %27,872 4.4 %
Selling, general and administrative92,282 28.3 %92,525 29.1 %182,227 28.1 %189,271 29.6 %
Total operating expenses107,659 33.0 %106,490 33.5 %211,537 32.6 %217,143 34.0 %
Operating income$48,781 15.0 %$42,872 13.5 %$100,167 15.4 %$87,207 13.6 %
References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation and sales recorded from acquired companies prior to the first anniversary date of their acquisition. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.
Net sales for the three months ended January 31, 2023 increased 2.6% to $326.2 million, compared to $318.1 million in the same period in the prior year. The increase consisted of organic sales growth of 6.3%, which was partially offset by a decrease from foreign currency translation of 3.7%. Organic sales grew 7.4% in the IDS segment and 2.8% in the WPS segment during the three months ended January 31, 2023 compared to the same period in the prior year.
Net sales for the six months ended January 31, 2023 increased 1.5% to $648.8 million, compared to $639.5 million in the same period in the prior year. The increase consisted of organic sales growth of 6.6%, which was partially offset by a decrease from foreign currency translation of 5.1%. Organic sales increased 8.0% in the IDS segment and 2.0% in the WPS segment during the six months ended January 31, 2023 compared to the same period in the prior year.
Gross margin increased 4.7% to $156.4 million in the three months ended January 31, 2023 compared to $149.4 million in the same period in the prior year. As a percentage of net sales, gross margin increased to 48.0% from 47.0% in the three-month period. Gross margin increased 2.4% to $311.7 million for the six months ended January 31, 2023 compared to $304.4 million in the same period in the prior year. As a percentage of net sales, gross margin increased to 48.0% from 47.6% in the six-month period. The increase in gross margin as a percentage of net sales was primarily due to our ongoing efforts to streamline manufacturing processes to drive sustainable operating efficiencies as well as price increases, which were partially offset by an increase in the cost of materials and labor.
R&D expenses increased 10.1% to $15.4 million in the three months ended January 31, 2023 compared to $14.0 million in the same period in the prior year. As a percentage of net sales, R&D expenses increased to 4.7% from 4.4% in the three-month period. R&D expenses increased 5.2% to $29.3 million in the six months ended January 31, 2023 compared to $27.9 million in the same period in the prior year. As a percentage of net sales, R&D expenses increased slightly to 4.5% from 4.4% in the six-month period. The Company remains committed to investing in new product development to increase sales within our IDS and WPS businesses. Investments in new printers, materials and the build out of industrial track and trace solutions remain the primary focus of R&D expenditures for the remainder of fiscal 2023.
SG&A expenses include selling and administrative costs directly attributed to the IDS and WPS segments, as well as certain other corporate administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A expenses decreased 0.3% to $92.3 million in the three months ended January 31, 2023 compared to $92.5 million in the same period in the prior year. As a percentage of net sales, SG&A decreased to 28.3% from 29.1% in the three-month period. SG&A expenses decreased 3.7% to $182.2 million for the six months ended January 31, 2023 compared to $189.3 million in the same period in the prior year. As a percentage of net sales, SG&A decreased to 28.1% from 29.6% in the six-month period. The decrease in SG&A expenses for the three and six-month periods ended January 31, 2023 was primarily due to foreign currency translation and, to a lesser extent, reductions in catalog advertising expenses within the WPS segment.
Operating income increased 13.8% to $48.8 million and increased 14.9% to $100.2 million for the three and six months ended January 31, 2023, respectively, compared to $42.9 million and $87.2 million in the same periods in the prior year. The
17
Table of Contents
increase in operating income in both the three and six-month periods was primarily due to the increase in segment profit in the IDS segment as a result of organic sales growth, and an increase in segment profit in the WPS segment due to its reduced cost structure.
OPERATING INCOME TO NET INCOME
Three months ended January 31,Six months ended January 31,
(Dollars in thousands)2023% Sales2022% Sales2023% Sales2022% Sales
Operating income $48,781 15.0 %$42,872 13.5 %$100,167 15.4 %$87,207 13.6 %
Other income (expense):
Investment and other income (expense)968 0.3 %(578)(0.2)%811 0.1 %(35)(0.0)%
Interest expense(1,239)(0.4)%(252)(0.1)%(2,133)(0.3)%(434)(0.1)%
Income before income taxes48,510 14.9 %42,042 13.2 %98,845 15.2 %86,738 13.6 %
Income tax expense10,524 3.2 %8,227 2.6 %21,418 3.3 %17,877 2.8 %
Net income$37,986 11.6 %$33,815 10.6 %$77,427 11.9 %$68,861 10.8 %
Investment and other income was $1.0 million and $0.8 million for the three and six months ended January 31, 2023, respectively, compared to investment and other expense of $0.6 million and $0.0 million in the same periods in the prior year. The increase in income during the three and six-month periods was primarily due to an increase in the market value of securities held in deferred compensation plans and to a lesser extent an increase in interest income.
Interest expense increased to $1.2 million and $2.1 million for the three and six months ended January 31, 2023, respectively, compared to $0.3 million and $0.4 million in the same periods in the prior year. The increase in interest expense was primarily due to an increase in benchmark interest rates compared to the same periods in the prior year.
The Company's income tax rate was 21.7% and 19.6% for the three months ended January 31, 2023 and 2022, respectively, and the income tax rate was 21.7% and 20.6% for the six months ended January 31, 2023 and 2022, respectively. Refer to Note L, "Income Taxes" for additional information on the Company's income tax rates.
Business Segment Operating Results
The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other income (expense), income tax expense, and certain corporate administrative expenses are excluded when evaluating segment performance.
18
Table of Contents
The following is a summary of segment information for the three and six months ended January 31, 2023 and 2022:
Three months ended January 31,Six months ended January 31,
2023202220232022
SALES GROWTH INFORMATION
IDS
Organic7.4 %16.0 %8.0 %14.6 %
Currency(3.0)%(1.7)%(4.3)%(0.5)%
Acquisitions— %11.8 %— %11.7 %
Total4.4 %26.1 %3.7 %25.8 %
WPS
Organic2.8 %5.2 %2.0 %(2.0)%
Currency(6.2)%(3.2)%(8.3)%(1.1)%
Total(3.4)%2.0 %(6.3)%(3.1)%
Total Company
Organic6.3 %13.1 %6.6 %10.0 %
Currency(3.7)%(2.1)%(5.1)%(0.7)%
Acquisitions— %8.6 %— %8.5 %
Total2.6 %19.6 %1.5 %17.8 %
SEGMENT PROFIT
IDS$47,384 $44,129 $98,909 $92,945 
WPS6,249 4,515 12,627 6,808 
Total$53,633 $48,644 $111,536 $99,753 
SEGMENT PROFIT AS A PERCENT OF NET SALES
IDS18.5 %18.0 %19.3 %18.8 %
WPS8.9 %6.2 %9.2 %4.7 %
Total16.4 %15.3 %17.2 %15.6 %
IDS
IDS net sales increased 4.4% to $255.7 million for the three months ended January 31, 2023 compared to $245.0 million in the same period in the prior year, which consisted of organic sales growth of 7.4% and a decrease from foreign currency translation of 3.0%. IDS net sales increased 3.7% to $512.0 million for the six months ended January 31, 2023 compared to $493.6 million in the same period in the prior year, which consisted of organic sales growth of 8.0% and a decrease from foreign currency translation of 4.3%. Organic sales grew in all major product lines with the strongest growth in the safety and facility identification and wire identification product lines, followed by growth in healthcare identification and product identification in both the three and six months ended January 31, 2023.
Organic sales in the Americas increased approximately 11% in the three months ended January 31, 2023 and increased in the high-single digits in the six months ended January 31, 2023 compared to the same periods in the prior year. Organic sales grew in all major product lines in the Americas with the strongest growth in the safety and facility identification and product identification product lines.
Organic sales in Europe increased in the mid-single digits in the three months ended January 31, 2023 and increased approximately 12% in the six months ended January 31, 2023 compared to the same periods in the prior year. Organic sales grew in all major product lines in Europe in both the three and six-month periods with the strongest growth in the product identification product line followed by growth in the safety and facility identification and wire identification product lines.
Organic sales in Asia declined in the high-single digits in the three months ended January 31, 2023 and declined in the low-single digits in the six months ended January 31, 2023 compared to the same periods in the prior year. The organic sales decline was primarily driven by decreased sales in China due to the spread of COVID-19 during the three-month period. The organic sales declines in China were partially offset by strong sales growth in India and Japan during both the three and six-month periods.
Segment profit increased 7.4% to $47.4 million for the three months ended January 31, 2023 compared to $44.1 million in the same period in the prior year. Segment profit increased 6.4% to $98.9 million for the six months ended January 31, 2023 compared to $92.9 million in the same period in the prior year. As a percentage of net sales, segment profit increased to 18.5% from 18.0% for the three-month period, and segment profit increased to 19.3% from 18.8% for the six-month period ended
19
Table of Contents
January 31, 2023 compared to the same periods in the prior year. The increase in segment profit as a percentage of net sales was primarily due to ongoing efforts to streamline processes to drive operational efficiencies as well as price increases, which were partially offset by an increase in costs due to inflationary pressures.
WPS
WPS net sales declined 3.4% to $70.6 million for the three months ended January 31, 2023 compared to $73.1 million in the same period in the prior year, which consisted of organic sales growth of 2.8% and a decrease from foreign currency translation of 6.2%. Organic digital sales increased approximately 12% while organic sales from all other channels, including catalogs, were flat during the three-month period ended January 31, 2023.
WPS net sales declined 6.3% to $136.8 million for the six months ended January 31, 2023 compared to $145.9 million in the same period in the prior year, which consisted of organic sales growth of 2.0% and a decrease from foreign currency translation of 8.3%. Organic digital sales increased by approximately 13% while organic sales from all other channels, including catalogs, decreased in the low-single digits in the six-month period ended January 31, 2023.
Organic sales in Europe increased in the low-single digits in both the three and six months ended January 31, 2023 compared to the same periods in the prior year. Organic digital sales increased approximately 12% while organic sales from all other channels, including catalogs, were essentially flat in both the three and six-month periods ended January 31, 2023.
Organic sales in North America declined in the mid-single digits in the three months ended January 31, 2023 compared to the same period in the prior year. Organic digital sales increased approximately 13% while organic sales from all other channels, including catalogs, declined nearly 20% during the three months ended January 31, 2023. Organic sales in North America declined in the high-single digits in the six months ended January 31, 2023 compared to the same period in the prior year. Organic digital sales increased nearly 20% which was more than offset by a decline of nearly 20% in organic sales from all other channels, including catalogs, in the six-month period ended January 31, 2023.
Organic sales in Australia increased in the mid-teens in both the three and six months ended January 31, 2023 compared to the same periods in the prior year. Organic sales were driven by consistent growth in both digital and sales from all other channels, including catalogs, in both the three and six-month periods, which was primarily the result of price increases implemented throughout the six months ended January 31, 2023.
Segment profit increased 38.4% to $6.2 million from $4.5 million, and as a percentage of net sales, segment profit increased to 8.9% from 6.2% for the three months ended January 31, 2023 compared to the same period in the prior year. Segment profit increased 85.5% to $12.6 million from $6.8 million and as a percentage of net sales, segment profit increased to 9.2% from 4.7% for the six months ended January 31, 2023 compared to the same period in the prior year. The increase in segment profit for both periods was primarily due to actions taken during fiscal 2022 to reduce the cost structure as well as ongoing reductions in catalog advertising expenses.
Liquidity and Capital Resources
The Company's cash balances are generated and held in numerous locations throughout the world. At January 31, 2023, approximately 99% of the Company's cash and cash equivalents were held outside the United States. The Company's organic and inorganic growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, research and development, common stock repurchases, and dividend payments for the next 12 months and beyond. Although the Company believes these sources of cash are currently sufficient to fund domestic operations, annual cash needs could require repatriation of cash to the U.S. from foreign jurisdictions, which may result in additional tax payments.
20
Table of Contents
Cash Flows
Cash and cash equivalents were $108.2 million at January 31, 2023, a decrease of $5.9 million from July 31, 2022. The significant changes were as follows:
 Six months ended January 31,
(Dollars in thousands)20232022
Net cash flow provided by (used in):
Operating activities$57,384 $24,328 
Investing activities(8,156)(16,381)
Financing activities(57,128)(4,505)
Effect of exchange rate changes on cash2,041 (3,370)
Net (decrease) increase in cash and cash equivalents$(5,859)$72 
Net cash provided by operating activities was $57.4 million for the six months ended January 31, 2023 compared to $24.3 million in the same period of the prior year. The increase in cash provided by operating activities was primarily due to reduced inventory purchases compared to increased inventory purchases in the prior year in order to reduce the risk of supply chain disruption.
Net cash used in investing activities was $8.2 million in the six months ended January 31, 2023 compared to $16.4 million in the same period of the prior year, which consisted primarily of capital expenditures in both periods. Prior year capital expenditures were elevated due to the purchase of two facilities that were previously leased.
Net cash used in financing activities was $57.1 million in the six months ended January 31, 2023 compared to $4.5 million in the same period of the prior year. The increase in cash used by financing activities was primarily due to $17.7 million of net repayments on the credit agreement in the six months ended January 31, 2023 compared to $45.0 million of net borrowings on the credit agreement in the same period of the prior year, which was due to the increase in net cash provided by operating activities in the current six-month period.
Material Cash Requirements
Our material cash requirements for known contractual obligations include capital expenditures, borrowings on our credit agreement and lease obligations. We believe that net cash provided by operating activities will continue to be adequate to meet our liquidity and capital needs for these items over the next 12 months and in the long-term beyond the next 12 months. We also have cash requirements for purchase orders and contracts for the purchase of inventory and other goods and services, which are based on current and anticipated customer needs and are fulfilled by our suppliers within short time horizons. We do not have significant agreements for the purchase of inventory or other goods or services specifying minimum order quantities. In addition, we may have liabilities for uncertain tax positions, but we do not believe that the cash requirements to meet any of these liabilities will be material.
Credit Agreement
On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency credit agreement with a group of five banks.
On December 21, 2021, the Company and certain of its subsidiaries entered into an amendment to the credit agreement dated August 1, 2019. The amendment modified the credit agreement to, among other things, (a) change the interest rate under the credit agreement for borrowings (i) denominated in British Pounds from the London Inter-bank Offered Rate ("LIBOR") to a daily simple SONIA-based rate, (ii) denominated in Euro from a LIBOR-based rate to a rate based on the Euro Interbank Offered Rate and (iii) denominated in Japanese Yen from a LIBOR-based rate to a rate based on the Tokyo Interbank Offered Rate, in each of the foregoing cases subject to certain adjustments specified in the credit agreement; and (b) provide mechanics relating to a transition away from U.S. dollar LIBOR (with respect to borrowings denominated in U.S. dollars) and the designated benchmarks for the other eligible currencies as benchmark interest rates and the replacement of any such benchmark by a replacement benchmark rate. The amendment to the credit agreement did not have a material impact on the interest rate or related balances in the Company's consolidated financial statements.
On November 14, 2022, the Company and certain of its subsidiaries entered into a Second Amendment to Credit Agreement (“Amendment No. 2”) with a group of six banks, which amended the original credit agreement dated August 1, 2019. Amendment No. 2 amended the credit agreement to, among other items, (a) increase the lending commitments by $100 million for total lending commitments of $300 million, (b) extend the final maturity date to November 14, 2027, (c) increase the
21
Table of Contents
interest rate on certain borrowings by 0.125%, and (d) increase the available amount under the credit agreement, at the Company's option and subject to certain conditions, from $300 million up to (i) an amount equal to the incremental borrowing necessary to bring the Company's consolidated net debt-to-EBITDA ratio as defined in the credit agreement to 2.5 to 1.0 plus (ii) $200 million. Borrowings under Amendment No. 2 are unsecured and are guaranteed by certain of the Company's domestic subsidiaries.
As of January 31, 2023, the outstanding balance on the Company's credit agreement was $77.3 million. The maximum amount outstanding on the credit agreement during the six months ended January 31, 2023 was $103.0 million. As of January 31, 2023, the U.S. dollar-denominated borrowings of $38.3 million bear interest at 5.6%; the Euro-denominated borrowings of €20.0 million bear interest at 2.9%; and the British Pound-denominated borrowings of £17.3 million bear interest at 4.3% for a weighted average interest rate of 4.5%. The Company had letters of credit outstanding under the credit agreement of $1.6 million as of January 31, 2023, and there was $221.1 million available for future borrowing, which can be increased to $981.1 million at the Company's option, subject to certain conditions. The credit agreement has a final maturity date of November 14, 2027. As such, borrowings were classified as long-term on the condensed consolidated balance sheets.
Covenant Compliance
The Company's credit agreement requires it to maintain certain financial covenants, including a ratio of debt to the trailing twelve months EBITDA, as defined in the credit agreement, of not more than a 3.5 to 1.0 ratio (leverage ratio) and the trailing twelve months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of January 31, 2023, the Company was in compliance with these financial covenants, with a ratio of debt to EBITDA, as defined by the agreement, equal to 0.31 to 1.0 and the interest expense coverage ratio equal to 85.9 to 1.0.
Forward-Looking Statements
In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.
The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:
•Increased cost of raw materials, labor and freight as well as raw material shortages and supply chain disruptions
•Decreased demand for the Company's products
•Ability to compete effectively or to successfully execute the Company's strategy
•Ability to develop technologically advanced products that meet customer demands
•Ability to identify, integrate, and grow acquired companies, and to manage contingent liabilities from divested businesses
•Adverse impacts of the novel coronavirus ("COVID-19") pandemic or other pandemics
•Difficulties in protecting websites, networks, and systems against security breaches and difficulties in preventing phishing attacks, social engineering or malicious break-ins
•Risks associated with the loss of key employees
•Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities
•Litigation, including product liability claims
•Foreign currency fluctuations
•Potential write-offs of goodwill and other intangible assets
•Changes in tax legislation and tax rates
•Differing interests of voting and non-voting shareholders
•Numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2022.
These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.
22
Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Refer to the Company’s Annual Report on Form 10-K for the year ended July 31, 2022. There has been no material change in this information since July 31, 2022.

ITEM 4. CONTROLS AND PROCEDURES
Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President & Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.
There were no changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
23
Table of Contents
PART II. OTHER INFORMATION
ITEM 1A. RISK FACTORS
The Company’s business, results of operations, financial condition, and cash flows are subject to various risks and uncertainties, including those described in Part I, Item 1A, “Risk Factors” of Company’s Annual Report on Form 10-K for the year ended July 31, 2022. There have been no material changes from the risk factors set forth in the 2022 Form 10-K.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The Company has a share repurchase program for the Company's Class A Nonvoting Common Stock. The repurchase program may be implemented by purchasing shares in the open market or in privately negotiated transactions, with repurchased shares available for use in connection with the Company's stock-based plans and for other corporate purposes. On May 24, 2022, the Company's Board of Directors authorized an increase in the Company's share repurchase program, authorizing the repurchase of up to $100.0 million of the Company's Class A Nonvoting Common Stock. As of January 31, 2023, there were $67.1 million worth of shares authorized to purchase remaining pursuant to the existing share repurchase program.
The following table provides information with respect to the purchases by the Company of Class A Nonvoting Common Stock during the three months ended January 31, 2023:
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced PlansApproximate Dollar Value of Shares that May Yet Be Purchased Under the Plan
(Dollars in Thousands)
November 1, 2022 - November 30, 2022— $— — $72,939 
December 1, 2022 - December 31, 2022123,321 46.92 123,321 67,153 
January 1, 2023 - January 31, 2023100 45.99 100 67,148 
Total123,421 $46.92 123,421 $67,148 
24
Table of Contents
ITEM 6. EXHIBITS
Exhibit No.Exhibit Description
10.1
Original Employment Contract between the Company and Brett Wilms effective June 1, 2018 (incorporated by reference to Registrant's Current Report on Form 8-K filed February 1, 2023).*
10.2
Employment Contract Addendum between the Company and Brett Wilms effective February 1, 2023 (incorporated by reference to Registrant's Current Report on Form 8-K filed February 1, 2023).*
10.3
Change of Control Agreement between the Company and Brett Wilms dated as of January 10, 2023 (incorporated by reference to Registrant's Current Report on Form 8-K filed February 1, 2023).*
31.1
31.2
32.1
32.2
101.INSXBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.)
101.SCHXBRL Taxonomy Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Presentation Label Linkbase Document
104Cover Page Inline XBRL data (contained in Exhibit 101)
*Management contract or compensatory plan or arrangement
25
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
      BRADY CORPORATION
Date: February 24, 2023 /s/ RUSSELL R. SHALLER
 Russell R. Shaller
 President and Chief Executive Officer
 (Principal Executive Officer)
Date: February 24, 2023   /s/ AARON J. PEARCE
   Aaron J. Pearce
   Chief Financial Officer and Treasurer
   (Principal Financial Officer)

26

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com